Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera

The Independent UK

Why the Recovery in Pfizer Stock Could Be Bigger Than Investors Expect

Pfizer is quietly laying the foundation for a new era of sustainable growth.

Barchart

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market

Pfizer Inc. (NYSE:PFE) stock climbed 1.54% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ:MTSR), a developer of anti-obesity drugs.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

The 5 Best Dividend Stocks to Buy for Steady Income in 2025

Here are five “set-and-forget” dividend stocks.

Barchart

Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap?

Investors love blue-chip stocks that pay fat dividends, but high yield alone doesn’t guarantee a safe income stream.

Benzinga

Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump administration health officials intend to link the vaccines to 25 child deaths. This assertion is reportedly based on unverified submissions to the Vaccine…

Benzinga

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) reported topline Phase 3 results for their LP.8.1-adapted monovalent COMIRNATY (2025-2026 Formula) in high-risk adults.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

We risk a deluge of AI-written ‘science’ pushing corporate interests – here’s what to do about it

Back in the 2000s, the American pharmaceutical firm Wyeth was sued by thousands of women who had developed breast cancer after taking its hormone replacement drugs. Court filings revealed the role of “dozens of ghostwritten reviews and commentaries published in medical journals and supplements being used to promote unproven benefits…

The Conversation

Donald Trump undermines his one lonely success that is apparently his one-way ticket to the Nobel Peace Prize

Looks like he is running out of things to destroy.

We Got This Covered

Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' (CORRECTED)

Editor’s Note: This article has been updated to reflect the correct year-to-date performance of Moderna stock.

Benzinga

Pfizer CEO is latest to say Trump should get Nobel Peace Prize – for something much of MAGA hates

Vaccine makers are publicly defending Covid-era achievements as the Trump administration rolls back vaccine approvals and cuts research funding

The Independent UK

What you need to know about Covid vaccines in the US this fall

In a move praised by RFK Jr, the FDA approved a new shot, but only for some people – here’s what to know about who can get them, and where

The Guardian - US

‘I want it NOW’: Trump wants ‘justifications’, rich coming from a guy who’s spent his entire career dodging them

He wants proof.

We Got This Covered

Is Pfizer Stock Underperforming the Nasdaq?

Although Pfizer has underperformed the Nasdaq recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions

President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs.

Benzinga

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works

Former Centers for Disease Control and Prevention immunizations chief Demetre Daskalakis said Sunday he resigned because politics has overrun science at the nation's top public-health agency, warning he "only see[s] harm coming" under Health and Human Services Secretary Robert F. Kennedy Jr.

Al Jazeera

Who can get updated COVID-19 vaccines in the US now?

FDA has approved COVID shots for people aged 65+ and at high risk; others need a doctor’s order.

The Guardian - US

RFK Jr faces calls to quit as CDC chief fired and senior staff resign: ‘an embarrassment’

Susan Monarez’s ousting and four top resignations follow vaccine confusion, leaving US health agencies in turmoil

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

The Latest: White House says CDC director is fired, agency leaders resign

The director of the nation’s top public health agency is challenging a White House announcement that she's been fired, and several other top leaders of the U.S. Centers for Disease Control and Prevention have resigned, saying President Donald Trump’s administration is putting politics in the way of keeping Americans safe

The Conversation

FDA approves updated COVID-19 vaccines with new restrictions, potentially limiting access for healthy children

Guidance around COVID-19 vaccines has once again shifted after the Food and Drug Administration on Aug. 27, 2025, approved updated shots for the fall season, but for a more limited group than in prior seasons.

Benzinga

RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines

Health and Human Services Secretary Robert F. Kennedy Jr. announced on social media that the emergency use authorizations for COVID-19 vaccines have now been rescinded.

The Guardian - US

FDA approves new Covid-19 vaccines in US but limits who can get them

Agency authorizes shots for those 65 and older, with young people eligible if they have underlying medical conditions

Barchart

Unusual Put Option Activity in Pfizer Stock - Have Investors Turned Bearish?

Barchart reports that Pfizer stock is showing unusual put option activity in yesterday's trading. Does that mean investors have turned bearish? Not necessarily, especially given the company's upgraded guidance.

The Independent UK

FDA approves updated COVID-19 shots but limits access for some kids and adults

The Food and Drug Administration has approved updated COVID-19 vaccines for the upcoming fall and winter season

Benzinga

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'

The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market "within months," according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Centers for Disease Control and Prevention

Health and Human Services

244 stories

205 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.